RxDoctor Payments DataLook up a doctor →

Peter Duros, MD

Internal Medicine · Orem, UTNPI 1669498119

Payments from drug & device makers

$7,661in general payments, 2019–2025

Across 481 payments — averaging $15.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Pfizer$613
  • Boehringer Ingelheim$481
  • Mylan Specialty L.p.$429
  • Lilly USA, LLC$427
  • Amgen$393
  • plus $4K from 48 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)95$1,618
Pfizer48$613
Boehringer Ingelheim28$481
Mylan Specialty L.p.26$429
Lilly USA, LLC36$427
Amgen22$393
GSK21$341
Astellas Pharma US Inc18$314
Bayer12$204
AstraZeneca15$204
Novo Nordisk12$188
Sanofi-aventis U.S. LLC11$177
Johnson & Johnson17$176
Otsuka America Pharmaceutical, Inc.10$163
Novartis8$143
Sunovion Pharmaceuticals Inc.12$142
Boston Scientific7$127
Sanofi Pasteur Inc.5$123
Sumitomo Pharma America, Inc.7$96
Phathom Pharmaceuticals, Inc.6$92
Lundbeck LLC4$83
Viatris Specialty LLC3$81
Merck5$79
Abbott4$73
Kowa Pharmaceuticals America, Inc.1$65
Dexcom, Inc.3$60
Supernus Pharmaceuticals, Inc.3$48
Actelion Pharmaceuticals US, Inc.2$46
Biohaven Pharmaceuticals, Inc.3$43
Edwards Lifesciences2$42
Teva Pharmaceuticals USA, Inc.3$41
Nestle Healthcare Nutrition Inc.2$41
Biohaven Pharmaceutical Holding Company Ltd.2$40
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$39
Arbor Pharmaceuticals, Inc.3$37
Nevro Corp.1$32
Axsome Therapeutics, Inc.2$32
Globus Medical1$30
Exact Sciences2$29
Amarin Pharma, Inc.2$28
Madrigal Pharmaceuticals1$26
Medtronic(2 entities)2$24
GE HealthCare1$22
Xeris Pharmaceuticals, Inc.1$22
Inspire Medical Systems, Inc.1$19
Impel Pharmaceuticals Inc.1$17
E.r. Squibb & Sons, L.L.C.1$16
Azurity Pharmaceuticals, Inc.1$16
Almatica Pharma LLC1$16
MDD US Operations, LLC1$14
Neurocrine Biosciences, Inc.1$14
Ironwood Pharmaceuticals, Inc1$13
Therapeuticsmd, Inc.1$12
Ironshore Pharmaceuticals Inc.1$12

How this compares

$7,661 in reported general payments places this provider in the 85th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$246,594
Medicare patients
485
Services billed
19,074

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Orem

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →